Short-duration chemoprophylaxis might reduce incidence of deep vein thrombosis in Asian patients undergoing total knee arthroplasty
0
조회
0
다운로드
1
인용
0
참고문헌
초록
Venous thromboembolism (VTE) is a serious complication that may occur after total knee arthroplasty (TKA), leading to the recommendation of routine chemoprophylaxis by international guidelines. This study aims to determine if short-duration chemoprophylaxis after TKA reduces the incidence of VTE in an Asian population.A retrospective study of 316 patients who underwent unilateral primary TKA between 1 January 2011 and 31 December 2013 was conducted. All patients received mechanical prophylaxis. One hundred seventeen patients (37%) received additional chemoprophylaxis, whereas 199 patients (63%) did not. A Doppler ultrasound (DUS) of both lower limbs was conducted for all patients within 6 days after surgery (median = 3 days) to assess for both proximal and distal DVT. Chemoprophylaxis in the form of enoxaparin (low molecular weight heparin; LMWH), aspirin, or heparin was administered until patients had a normal DUS, for a median duration of 4 days. Patients were followed up clinically for a minimum of 6 months to monitor for delayed or recurrent VTE and at least 2 years for patient-reported outcome measures. Overall, 24 patients (7.59%) developed deep vein thrombosis (DVT): three proximal and 21 distal DVTs. Twenty-three of the 24 patients were asymptomatic. Twenty of 199 patients (10.05%) with only mechanical prophylaxis developed DVT, whereas four of 117 patients (3.42%) with additional chemoprophylaxis developed DVT. Multivariate analysis showed that chemoprophylaxis use was associated with reduced incidence of DVT (odds ratio = 0.19, p value = 0.011). Other factors associated with increased DVT incidence include female gender (odds ratio = 5.45, p value = 0.034), positive history of cancer (odds ratio = 5.14, p value = 0.044), and increased length of stay in hospital (odds ratio = 1.19, p value < 0.001). Our study has shown that despite the low incidence of DVT in Asian patients undergoing TKA, short-duration chemoprophylaxis might be effective in reducing the incidence of DVT. However, most DVTs observed in our study were distal and may be of limited clinical significance. Further studies are needed to investigate the impact of chemoprophylaxis use on the incidence of PE and overall mortality rates among Asian patients.
Abstract
Venous thromboembolism (VTE) is a serious complication that may occur after total knee arthroplasty (TKA), leading to the recommendation of routine chemoprophylaxis by international guidelines. This study aims to determine if short-duration chemoprophylaxis after TKA reduces the incidence of VTE in an Asian population.A retrospective study of 316 patients who underwent unilateral primary TKA between 1 January 2011 and 31 December 2013 was conducted. All patients received mechanical prophylaxis. One hundred seventeen patients (37%) received additional chemoprophylaxis, whereas 199 patients (63%) did not. A Doppler ultrasound (DUS) of both lower limbs was conducted for all patients within 6 days after surgery (median = 3 days) to assess for both proximal and distal DVT. Chemoprophylaxis in the form of enoxaparin (low molecular weight heparin; LMWH), aspirin, or heparin was administered until patients had a normal DUS, for a median duration of 4 days. Patients were followed up clinically for a minimum of 6 months to monitor for delayed or recurrent VTE and at least 2 years for patient-reported outcome measures. Overall, 24 patients (7.59%) developed deep vein thrombosis (DVT): three proximal and 21 distal DVTs. Twenty-three of the 24 patients were asymptomatic. Twenty of 199 patients (10.05%) with only mechanical prophylaxis developed DVT, whereas four of 117 patients (3.42%) with additional chemoprophylaxis developed DVT. Multivariate analysis showed that chemoprophylaxis use was associated with reduced incidence of DVT (odds ratio = 0.19, p value = 0.011). Other factors associated with increased DVT incidence include female gender (odds ratio = 5.45, p value = 0.034), positive history of cancer (odds ratio = 5.14, p value = 0.044), and increased length of stay in hospital (odds ratio = 1.19, p value < 0.001). Our study has shown that despite the low incidence of DVT in Asian patients undergoing TKA, short-duration chemoprophylaxis might be effective in reducing the incidence of DVT. However, most DVTs observed in our study were distal and may be of limited clinical significance. Further studies are needed to investigate the impact of chemoprophylaxis use on the incidence of PE and overall mortality rates among Asian patients.
참고문헌 (30)
- John Richmond, "American Academy of Orthopaedic Surgeons Clinical Practice Guideline on The Treatment of Osteoarthritis (OA) of the Knee", The Journal of Bone and Joint Surgery-American Volume, 92(4), pp.990~993 (2010), Ovid Technologies (Wolters Kluwer Health)[DOI]
- Howie C, "Venous thromboembolism associated with hip and knee replacement over a ten-year period : a population-based study", J Bone Joint Surg(Br), 87(12), pp.1675~1680 (2005)[DOI]
- Parvizi J, "Venous thromboembolism following hip and knee arthroplasty : the role of aspirin", J Bone Joint Surg Am, 99, pp.961~972 (2017)[DOI]
- National Institute of Health and Care Excellence, "NICE clinical guideline 89:venous thromboembolism in over 16s: reducing the risk of hospitalacquired deep vein thrombosis or pulmonary embolism", ~ (2018)
- Jacobs JJ, "American Academy of Orthopaedic Surgeons clinical practice guideline on : preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty", J Bone Joint Surg Am, 94(8), pp.746~747 (2012)
- Yassin M, "The necessity of pharmacological prophylaxis against venous thromboembolism in major joint arthroplasty", Int Orthop, 38(5), pp.1073~1075 (2014)[DOI]
- Gill SK, "Mechanical prophylaxis, early mobilisation and risk stratification: as effective as drugs for low risk patients undergoing primary joint replacement. Results in 13,384 patients", Surgeon, 18(4), pp.219~225 (2019)
- B Kanchanabat, "Systematic review and meta-analysis on the rate of postoperative venous thromboembolism in orthopaedic surgery in Asian patients without thromboprophylaxis", British Journal of Surgery, 98(10), pp.1356~1364 (2011), Oxford University Press (OUP)[DOI]
- Kang-Ling Wang, "The diagnosis and treatment of venous thromboembolism in Asian patients", Thrombosis Journal, 16(1) (2018), Springer Science and Business Media LLC[DOI]
- Man-Hee Won, "Prevalence and Risk Factors of Thromboembolism After Joint Arthroplasty Without Chemical Thromboprophylaxis in an Asian Population", The Journal of Arthroplasty, 26(7), pp.1106~1111 (2011), Elsevier BV[DOI]
- 박신형, "Incidences of Deep Vein Thrombosis and Pulmonary Embolism after Total Knee Arthroplasty Using a Mechanical Compression Device with and without Low-Molecular-Weight Heparin", Knee Surgery and Related Research, 28(3), pp.213~218 (2016), 대한슬관절학회
- Loh JLM, "Chemoprophylaxis in addition to mechanical prophylaxis after total knee arthroplasty surgery does not reduce the incidence of venous thromboembolis", Thromb J, 17, pp.9~ (2019)
- Young-Hoo Kim, "Mechanical thromboprophylaxis would suffice after total knee arthroplasties in Asian patients?", Archives of Orthopaedic and Trauma Surgery, 139(2), pp.167~171 (2019), Springer Science and Business Media LLC[DOI]
- Kye-Youl Cho, "Is routine chemoprophylaxis necessary for prevention of venous thromboembolism following knee arthroplasty in a low incidence population?", Archives of Orthopaedic and Trauma Surgery, 133(4), pp.551~559 (2013), Springer Science and Business Media LLC[DOI]
- Vincent V. G An, "Thrombosis rates using aspirin and a compression device as multimodal prophylaxis for lower limb arthroplasty in a screened population", Journal of Clinical Orthopaedics and Trauma, 11, pp.S187~S191 (2020), Elsevier BV[DOI]
- Hansrani V, "The diagnosis and management of early deep vein thrombosis", Adv Exp Med Biol, 906, pp.23~31 (2017)[DOI]
- Shannon M. Bates, "Diagnosis of DVT", Chest, 141(2), pp.e351S~e418S (2012), Elsevier BV[DOI]
- Marc Righini, "Clinical relevance of distal deep vein thrombosis", Current Opinion in Pulmonary Medicine, 14(5), pp.408~413 (2008), Ovid Technologies (Wolters Kluwer Health)[DOI]
- Helia Robert-Ebadi, "Should we diagnose and treat distal deep vein thrombosis?", Hematology, 2017(1), pp.231~236 (2017), American Society of Hematology[DOI]
- Falck-Ytter Y, "Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed:American College of Chest Physicians evidence-based clinical practice guidelines", Chest, 141(2 Suppl), pp.e278S~e325S (2012)
- Anderson DR, "American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients", Blood Adv, 3(23), pp.3898~3944 (2019)
- Rachel Forster, "Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair", Cochrane Database of Systematic Reviews (2016), Wiley[DOI]
- 김강일, "Thromboprophylaxis for Deep Vein Thrombosis and Pulmonary Embolism after Total Joint Arthroplasty in a Low Incidence Population", Knee Surgery and Related Research, 25(2), pp.43~53 (2013), 대한슬관절학회
- E. O. Pearse, "Early mobilisation after conventional knee replacement may reduce the risk of postoperative venous thromboembolism", The Journal of Bone and Joint Surgery. British volume, 89-B(3), pp.316~322 (2007), British Editorial Society of Bone & Joint Surgery[DOI]
- Pelle Petersen, "Safety of In-Hospital Only Thromboprophylaxis after Fast-Track Total Hip and Knee Arthroplasty: A Prospective Follow-Up Study in 17,582 Procedures", Thrombosis and Haemostasis, 118(12), pp.2152~2161 (2018), Georg Thieme Verlag KG[DOI]
- Masuda EM, "The controversy of managing calf vein thrombosis", J Vasc Surg, 55(2), pp.550~561 (2012)[DOI]
- Clive Kearon, "Antithrombotic Therapy for VTE Disease", Chest, 141(2), pp.e419S~e496S (2012), Elsevier BV[DOI]
- Gualtiero Palareti, "Do isolated calf deep vein thrombosis need anticoagulant treatment?", Journal of Thoracic Disease, 8(12), pp.E1691~E1693 (2016), AME Publishing Company[DOI]
- Moon Jong Chang, "Incidence of deep vein thrombosis before and after total knee arthroplasty without pharmacologic prophylaxis: a 128-row multidetector CT indirect venography study", BMC Musculoskeletal Disorders, 19(1) (2018), Springer Science and Business Media LLC[DOI]
- Bhatt M, "Diagnosis of deep vein thrombosis of the lower extremity : a systematic review and meta-analysis of test accuracy", Blood Adv, 14(7), pp.1250~1264 (2020)[DOI]